1
|
Closset M, Colsoul ML, Goderniaux N, Bihin B, Jamart J, Onorati S, Soumoy L, Hecq JD, Odou P, Galanti L. An ultra-high-performance chromatography method to study the long term stability of gemcitabine in dose banding conditions. J Pharm Biomed Anal 2023; 227:115290. [PMID: 36812796 DOI: 10.1016/j.jpba.2023.115290] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/14/2022] [Revised: 02/11/2023] [Accepted: 02/11/2023] [Indexed: 02/17/2023]
Abstract
Gemcitabine is an analogue of cytidine arabinoside, used alone or in combination chemotherapy to treat various type of cancer. The dose-banding of gemcitabine provides the opportunity to anticipate the preparation of this anticancer drug on condition of carrying out stability studies. The aim of this study is to develop and validate a stability-indicating ultra-high-performance Liquid Chromatography (UHPLC) method for measuring the concentration of gemcitabine and to evaluate its stability at standardised rounded doses in polyolefin bags. The UHPLC with photodiode array (PDA) detector method was developed and validated (linearity, precision, accuracy, limits of detection and quantification, robustness and degradation test). Thirty polyolefin bags of gemcitabine (1600 mg/292 ml (n = 10), 1800 mg/297 ml (n = 10) and 2000 mg/303 ml (n = 10)) were prepared under aseptic conditions and stored at 5 ± 3 °C and 23 ± 2 °C for 49 days. Physical stability tests were periodically performed: visual and microscopic inspection and optical densities. The chemical stability was evaluated through pH monitoring and chromatographic assays. The results confirm the stability of Gemcitabine at selected standardised rounded doses of 1600 mg, 1800 mg and 2000 mg in NaCl 0.9% polyolefin bags for at least 49 days at 5 ± 3 °C and 23 ± 2 °C, allowing in-advance preparation.
Collapse
Affiliation(s)
- Mélanie Closset
- Medical Laboratory, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium.
| | - Marie-Lise Colsoul
- Medical Laboratory, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Nicolas Goderniaux
- Medical Laboratory, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Benoît Bihin
- Scientific Support Unit, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Jacques Jamart
- Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Sabrina Onorati
- Medical Laboratory, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Laura Soumoy
- Department of Pharmacy, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Jean-Daniel Hecq
- Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| | - Pascal Odou
- Université de Lille, CHU Lille, ULR7365 - GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000 Lille, France
| | - Laurence Galanti
- Medical Laboratory, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium; Drug Stability Research Group, CHU UCL Namur, 1 Avenue Therasse, 5530 Yvoir, Belgium
| |
Collapse
|
2
|
Das A, Das A, Banik BK. Tellurium-based chemical sensors. PHYSICAL SCIENCES REVIEWS 2022. [DOI: 10.1515/psr-2021-0116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Abstract
The various tellurium-based chemical sensors are described. This article focuses on four types of Tellurium sensors such as CdTe quantum dots-based sensor, Te thin films-based sensor, Te nanostructures or nanoparticles-based sensor, and TeO2-based sensor.
Collapse
Affiliation(s)
- Anjaly Das
- National Institute of Electronics & Information Technology , Calicut 673601 , Kerala , India
| | - Aparna Das
- Department of Mathematics and Natural Sciences , College of Sciences and Human Studies, Prince Mohammad Bin Fahd University , Al Khobar 31952 , Kingdom of Saudi Arabia
| | - Bimal Krishna Banik
- Department of Mathematics and Natural Sciences , College of Sciences and Human Studies, Prince Mohammad Bin Fahd University , Al Khobar 31952 , Kingdom of Saudi Arabia
| |
Collapse
|
3
|
Samide A, Tutunaru B, Varut RM, Oprea B, Iordache S. Interactions of Some Chemotherapeutic Agents as Epirubicin, Gemcitabine and Paclitaxel in Multicomponent Systems Based on Orange Essential Oil. Pharmaceuticals (Basel) 2021; 14:ph14070619. [PMID: 34199041 PMCID: PMC8308819 DOI: 10.3390/ph14070619] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2021] [Revised: 06/15/2021] [Accepted: 06/23/2021] [Indexed: 01/17/2023] Open
Abstract
In order to anticipate the effect induced by a natural product on the chemical activity of medicines simultaneously administered, spontaneous interactions of certain cancer treatment drugs such as, epirubicin (EPR), gemcitabine (GCT), and paclitaxel (PTX) with limonene (LIM)—a natural compound extracted from orange peel and known as an anticancer agent—were investigated. To estimate the stability of the drugs over time, a current density of 50 mA cm−2 was applied as an external stimulus between two platinum electrodes immersed in hydrochloric acid solution containing ethyl alcohol/water in the volume ratio of 2/3, in the absence and presence of orange essential oil (limonene concentration of 95%). The concentration variation of chemotherapeutic agents over time was evaluated by UV-Vis spectrophotometry. Kinetic studies have shown a delay in the decomposition reaction of epirubicin and gemcitabine and a paclitaxel activity stimulation. Thus, in the presence of limonene, the epirubicin half-life increased from 46.2 min to 63 min, and from 6.2 min to 8.6 min in gemcitabine case, while for paclitaxel a decrease of half-life from 35.9 min to 25.8 min was determined. Therefore, certain drug-limonene interactions took place, leading to the emergence of molecular micro-assemblies impacting decomposition reaction of chemotherapeutics. To predict drug–limonene interactions, the Autodock 4.2.6 system was employed. Thus, two hydrophobic interactions and five π-alkyl interactions were established between EPR-LIM, the GCT-LIM connection involves four π-alkyl interactions, and the PTX-LIM bridges take place through three hydrophobic interactions and the one π-alkyl. Finally, the decomposition reaction mechanism of drugs was proposed.
Collapse
Affiliation(s)
- Adriana Samide
- Chemistry Department, Faculty of Sciences, University of Craiova, Calea Bucuresti 107i, 200478 Craiova, Romania; (A.S.); (S.I.)
| | - Bogdan Tutunaru
- Chemistry Department, Faculty of Sciences, University of Craiova, Calea Bucuresti 107i, 200478 Craiova, Romania; (A.S.); (S.I.)
- Correspondence: ; Tel.: +40-251-597048
| | - Renata-Maria Varut
- Faculty of Pharmacy, University of Medicine and Pharmacy, Petru Rareş 2, 200349 Craiova, Romania;
| | - Bogdan Oprea
- Faculty of Medicine, University of Medicine and Pharmacy, Petru Rareş 2, 200349 Craiova, Romania;
| | - Simona Iordache
- Chemistry Department, Faculty of Sciences, University of Craiova, Calea Bucuresti 107i, 200478 Craiova, Romania; (A.S.); (S.I.)
- Faculty of Sciences, Doctoral School of Sciences, University of Craiova, A. I. Cuza 13, 200585 Craiova, Romania
| |
Collapse
|
4
|
Avataneo V, D’Avolio A, Cusato J, Cantù M, De Nicolò A. LC-MS application for therapeutic drug monitoring in alternative matrices. J Pharm Biomed Anal 2019; 166:40-51. [DOI: 10.1016/j.jpba.2018.12.040] [Citation(s) in RCA: 41] [Impact Index Per Article: 8.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/02/2018] [Revised: 12/24/2018] [Accepted: 12/26/2018] [Indexed: 12/14/2022]
|
5
|
Kurbanoglu S, Bakirhan NK, Gumustas M, Ozkan SA. Modern Assay Techniques for Cancer Drugs: Electroanalytical and Liquid Chromatography Methods. Crit Rev Anal Chem 2019; 49:306-323. [PMID: 30595027 DOI: 10.1080/10408347.2018.1527206] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
In the past decades, patients who have chemotherapy treatment have considerably increased number. At this point, the development of rapid precise, and reliable methods are very important to analyze cancer drugs from their dosage forms, animals or human biological samples. Among all the analytical methods, electrochemical methods hold an important position with their unique properties such as specificity in the biological recognition process, fast response, and their reliability and do not need a pretreatment process. Chromatographic methods are also used in a wide range of analytical applications for the analyses of anticancer drugs. The power of chromatography comes from its ability to separate a mixture of analytes and determination of their concentrations. Chromatographic techniques can mainly be divided into gas, liquid, and supercritical fluid chromatography. In the frame of this information, this review is aimed to provide basic principles of electroanalytical and high-performance liquid chromatography methods for the analysis of cancer drugs. In addition, some selected applications for electrochemistry-related techniques and high-performance liquid chromatography, for the determination of anti-cancer pharmaceuticals published in the last five years are also discussed.
Collapse
Affiliation(s)
- Sevinc Kurbanoglu
- a Faculty of Pharmacy, Department of Analytical Chemistry , Ankara University , Ankara , Turkey
| | - Nurgul K Bakirhan
- b Faculty of Science and Art, Department of Chemistry , Hitit University , Çorum , Turkey
| | - Mehmet Gumustas
- c Department of Forensic Toxicology , Ankara University Institute of Forensic Sciences , Ankara , Turkey
| | - Sibel A Ozkan
- a Faculty of Pharmacy, Department of Analytical Chemistry , Ankara University , Ankara , Turkey
| |
Collapse
|
6
|
Najafi S, Amani S, Shahlaei M. Rapid determination of the anti-cancer agent Gemcitabine in biological samples by fluorescence sensor based on Au-doped CdTe. J Mol Liq 2018. [DOI: 10.1016/j.molliq.2018.06.105] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
|
7
|
Gaudin A, Song E, King AR, Saucier-Sawyer JK, Bindra R, Desmaële D, Couvreur P, Saltzman WM. PEGylated squalenoyl-gemcitabine nanoparticles for the treatment of glioblastoma. Biomaterials 2016; 105:136-144. [PMID: 27521616 DOI: 10.1016/j.biomaterials.2016.07.037] [Citation(s) in RCA: 44] [Impact Index Per Article: 5.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2016] [Revised: 07/27/2016] [Accepted: 07/29/2016] [Indexed: 11/25/2022]
Abstract
New treatments for glioblastoma multiforme (GBM) are desperately needed, as GBM prognosis remains poor, mainly due to treatment resistance, poor distribution of therapeutics in the tumor tissue, and fast metabolism of chemotherapeutic drugs in the brain extracellular space. Convection-enhanced delivery (CED) of nanoparticles (NPs) has been shown to improve the delivery of chemotherapeutic drugs to the tumor bed, providing sustained release, and enhancing survival of animals with intracranial tumors. Here we administered gemcitabine, a nucleoside analog used as a first line treatment for a wide variety of extracranial solid tumors, within squalene-based NPs using CED, to overcome the above-mentioned challenges of GBM treatment. Small percentages of poly(ethylene) glycol (PEG) dramatically enhanced the distribution of squalene-gemcitabine nanoparticles (SQ-Gem NPs) in healthy animals and tumor-bearing animals after administration by CED. When tested in an orthotopic model of GBM, SQ-Gem-PEG NPs demonstrated significantly improved therapeutic efficacy compared to free gemcitabine, both as a chemotherapeutic drug and as a radiosensitizer. Furthermore, MR contrast agents were incorporated into the SQ-Gem-PEG NP formulation, providing a way to non-invasively track the NPs during infusion.
Collapse
Affiliation(s)
- Alice Gaudin
- Department of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA
| | - Eric Song
- Department of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA
| | - Amanda R King
- Department of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA
| | | | - Ranjit Bindra
- Department of Therapeutic Radiology, Yale School of Medicine, New Haven, CT, 06511, USA
| | - Didier Desmaële
- Institut Galien Paris-Sud, UMR CNRS 8612, University Paris-Sud XI, Châtenay-Malabry, 92290, France
| | - Patrick Couvreur
- Institut Galien Paris-Sud, UMR CNRS 8612, University Paris-Sud XI, Châtenay-Malabry, 92290, France
| | - W Mark Saltzman
- Department of Biomedical Engineering, Yale University, New Haven, CT, 06511, USA.
| |
Collapse
|